Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon Sedation Before Refractive Laser Vision Correction
NCT06080100Phase 1Completed
- Sponsor
- S. Fyodorov Eye Microsurgery Complex
- Start
- Nov 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of xenon in psychological stress and anxiety disorder (2 arms), sponsored by S. Fyodorov Eye Microsurgery Complex. Primary endpoints: Concentration of cortisol in the blood at 30 months, Glucose concentration in capillary blood at 30 months and 2 more. Started Nov 2023; status: completed.
02
Drugs
xenon
03
Conditions
psychological stressanxiety disorder
Beyond the preview
Go deeper on NCT06080100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080100.